Aethlon Medical
AEMD
21 hedge funds and large institutions have $171K invested in Aethlon Medical in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
5% less funds holding
Funds holding: 22 → 21 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
37% less capital invested
Capital invested by funds: $270K → $171K (-$99K)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.5K |
| 2 |
HF
HRT Financial
New York
|
+$5.39K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$1.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$257 |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$7K |
| 2 |
Mercer Global Advisors
Denver,
Colorado
|
-$5K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.65K |
| 4 |
Two Sigma Investments
New York
|
-$3.34K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.57K |
AEMD Hedge Fund Activity: Q3 2023 in Review
21 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2023, worth a combined $171K — down 37% from $270K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AEMD and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 3 added.
The largest buyer was Geode Capital Management, adding an estimated $10.5K. The largest seller was Virtu Financial, exiting entirely with an estimated $7K sold.
- 21 institutional investors held Aethlon Medical (AEMD) as of Q3 2023, down from 22 in Q2 2023.
- Funds reported $171K of Aethlon Medical stock for Q3 2023, down 37% quarter-over-quarter.
- 2 funds opened new Aethlon Medical positions in Q3 2023 and 3 closed out, a net change of -1 holder.
- The largest Aethlon Medical buyer in Q3 2023 was Geode Capital Management, an estimated $10.5K added.
- The largest Aethlon Medical seller in Q3 2023 was Virtu Financial, an estimated $7K sold.
Based on aggregated 13F filings for Q3 2023.